These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23126564)

  • 1. Antigenicity and epitope specificity of ZnT8 autoantibodies in type 1 diabetes.
    Skärstrand H; Lernmark A; Vaziri-Sani F
    Scand J Immunol; 2013 Jan; 77(1):21-9. PubMed ID: 23126564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zinc transporter 8 (ZnT8) autoantibody epitope specificity and affinity examined with recombinant ZnT8 variant proteins in specific ZnT8R and ZnT8W autoantibody-positive type 1 diabetes patients.
    Skärstrand H; Krupinska E; Haataja TJ; Vaziri-Sani F; Lagerstedt JO; Lernmark Å
    Clin Exp Immunol; 2015 Feb; 179(2):220-9. PubMed ID: 25178386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel triple mix radiobinding assay for the three ZnT8 (ZnT8-RWQ) autoantibody variants in children with newly diagnosed diabetes.
    Vaziri-Sani F; Delli AJ; Elding-Larsson H; Lindblad B; Carlsson A; Forsander G; Ivarsson SA; Ludvigsson J; Marcus C; Lernmark Å
    J Immunol Methods; 2011 Aug; 371(1-2):25-37. PubMed ID: 21708156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations between islet autoantibody specificity and the SLC30A8 genotype with HLA-DQB1 and metabolic control in new onset type 1 diabetes.
    Brorsson C; Vaziri-Sani F; Bergholdt R; Eising S; Nilsson A; Svensson J; Lernmark Å; Pociot F;
    Autoimmunity; 2011 Mar; 44(2):107-14. PubMed ID: 20836749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ZnT8 autoantibody titers in type 1 diabetes patients decline rapidly after clinical onset.
    Vaziri-Sani F; Oak S; Radtke J; Lernmark K; Lynch K; Agardh CD; Cilio CM; Lethagen AL; Ortqvist E; Landin-Olsson M; Törn C; Hampe CS
    Autoimmunity; 2010 Dec; 43(8):598-606. PubMed ID: 20298127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of HLA class I-restricted T-cell epitopes of islet autoantigen combined with binding and dissociation assays.
    Wu X; Xu X; Gu R; Wang Z; Chen H; Xu K; Zhang M; Hutton J; Yang T
    Autoimmunity; 2012 Mar; 45(2):176-85. PubMed ID: 22260783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple chimeric islet autoantigen IA2-ZnT8WR to facilitate islet autoantibody determination.
    Yu L; Liu Y; Miao D; Wenzlau J; Davidson H; Hutton J; Eisenbarth GS
    J Immunol Methods; 2010 Feb; 353(1-2):20-3. PubMed ID: 20035758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between autoantibodies to the Arginine variant of the Zinc transporter 8 (ZnT8) and stimulated C-peptide levels in Danish children and adolescents with newly diagnosed type 1 diabetes.
    Andersen ML; Vaziri-Sani F; Delli A; Pörksen S; Jacobssen E; Thomsen J; Svensson J; Steen Petersen J; Hansen L; Lernmark A; Mortensen HB; Nielsen LB
    Pediatr Diabetes; 2012 Sep; 13(6):454-62. PubMed ID: 22686132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between ZnT8Ab, the SLC30A8 gene and disease progression in children with newly diagnosed type 1 diabetes.
    Nielsen LB; Vaziri-Sani F; Pörksen S; Andersen ML; Svensson J; Bergholdt R; Pociot F; Hougaard P; de Beaufort C; Castaño L; Mortensen HB; Lernmark A; Hansen L;
    Autoimmunity; 2011 Dec; 44(8):616-23. PubMed ID: 21604969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiobinding assay for detecting autoantibodies to single epitopes.
    Lampasona V; Belloni C; Piquer S; Bonicchio S; Furlan R; Bonifacio E
    J Immunol Methods; 2008 Jul; 336(2):127-34. PubMed ID: 18501377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a luciferase-based system for the detection of ZnT8 autoantibodies.
    Ustinova J; Zusinaite E; Utt M; Metsküla K; Reimand K; Huchaiah V; Merits A; Uibo R
    J Immunol Methods; 2014 Mar; 405():67-73. PubMed ID: 24462542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of zinc transporter 8 (ZnT8) antibodies in autoimmune diabetic patients from Argentinian population using monomeric, homodimeric, and heterodimeric ZnT8 antigen variants.
    Faccinetti NI; Guerra LL; Penas Steinhardt A; Iacono RF; Frechtel GD; Trifone L; Poskus E; Trabucchi A; Valdez SN
    Eur J Endocrinol; 2016 Feb; 174(2):157-65. PubMed ID: 26567119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dynamic changes of zinc transporter 8 autoantibodies in Czech children from the onset of Type 1 diabetes mellitus.
    Petruzelkova L; Ananieva-Jordanova R; Vcelakova J; Vesely Z; Stechova K; Lebl J; Dusatkova P; Sumnik Z; Coles R; Powell M; Furmaniak J; Rees Smith B; Kolouskova S
    Diabet Med; 2014 Feb; 31(2):165-71. PubMed ID: 23952619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Could ZnT8 antibodies replace ICA, GAD, IA2 and insulin antibodies in the diagnosis of type 1 diabetes?
    Lounici Boudiaf A; Bouziane D; Smara M; Meddour Y; Haffaf EM; Oudjit B; Chaib Mamouzi S; Aouichat Bouguerra S
    Curr Res Transl Med; 2018 Mar; 66(1):1-7. PubMed ID: 29487039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of zinc transporter 8 and MAP3865c homologous epitopes by new-onset type 1 diabetes children from continental Italy.
    Masala S; Cossu D; Piccinini S; Rapini N; Massimi A; Porzio O; Pietrosanti S; Lidano R; Bitti ML; Sechi LA
    Acta Diabetol; 2014 Aug; 51(4):577-85. PubMed ID: 24496951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zinc transporter 8 and MAP3865c homologous epitopes are recognized at T1D onset in Sardinian children.
    Masala S; Zedda MA; Cossu D; Ripoli C; Palermo M; Sechi LA
    PLoS One; 2013; 8(5):e63371. PubMed ID: 23696819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive autoantibodies to ZnT8 indicate elevated risk for additional autoimmune conditions in patients with Addison's disease.
    Fichna M; Rogowicz-Frontczak A; Żurawek M; Fichna P; Gryczyńska M; Zozulińska-Ziółkiewicz D; Ruchała M
    Endocrine; 2016 Jul; 53(1):249-57. PubMed ID: 26972575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico identification and wet lab validation of novel cryptic B cell epitopes in ZnT8 zinc transporter autoantigen.
    Shruthi S; Mohan V; Maradana MR; Aravindhan V
    Int J Biol Macromol; 2019 Apr; 127():657-664. PubMed ID: 30710592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens.
    Bonifacio E; Lampasona V; Bingley PJ
    J Immunol; 1998 Sep; 161(5):2648-54. PubMed ID: 9725268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a major humoral epitope in Slc30A8 (ZnT8).
    Wenzlau JM; Moua O; Liu Y; Eisenbarth GS; Hutton JC; Davidson HW
    Ann N Y Acad Sci; 2008 Dec; 1150():252-5. PubMed ID: 19120306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.